Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
UNKNOWN
NA
100 participants
INTERVENTIONAL
2021-08-23
2023-08-01
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Temperature Study in Cesarean Section
NCT01249014
Prevention of Hypothermia During Caesarean Section: Continuous Core Temperature Monitoring With Zero-heat-flux
NCT04132154
Impact of Active Heating on Maternal and Neonatal Well-being
NCT06259942
Effect of a Warming Mattress on Perioperative Hypothermia Following Cesarean Delivery
NCT02837913
Effect of Maintenance of Intraoperative Normothermia in Cesarean Section on Thermal Comfort, Serum Cortisol and Apgar Score: A Randomized Controlled Trial
NCT06962241
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
PREVENTION
SINGLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Treatment
Preop: Use of full body forced air warming pre-operative at ambient (32˚C) for at least 30 minutes and fluids from warmed cabinet set at 45˚C
Intraop: Use of upper body and lower forced air warming intra-operative at 32 and 42˚C respectively and IV fluids with hotline fluid warmer set at 42˚C
Pre op upper body forced air warming (32˚C)
Use of upper body forced air warming at ambient (32˚C) for at least 30 minutes
Pre op lower body forced air warming (32˚C)
lower body forced air warming at ambient (32˚C) for at least 30 minutes
Pre op fluids (45˚C)
fluids from warmed cabinet set at 45˚C
Intra op upper body forced air warming (32˚C)
Use of upper body forced air warming intra-operative at ambient (32˚C)
Intra op upper body forced air warming at (32˚C)
upper body forced air warming intra-operative at ambient (32˚C)
Intra op upper body forced air warming at (42˚C)
upper body forced air warming intra-operative at ambient (42˚C)
Intra op lower body forced air warming at (32˚C)
Lower body forced air warming intra-operative at ambient (32˚C)
Intra op lower body forced air warming at (42˚C)
Lower body forced air warming intra-operative at ambient (42˚C)
Intra op fluid (42˚C)
IV fluids with hotline fluid warmer set at 42˚C
Control Group
Preop: Use of full body forced air warming pre-operative at ambient (32˚C) for at least 30 minutes and fluids from warmed cabinet set at 45˚C
Intraop: Use of upper body forced air warming intra-operative at ambient (32˚C) and IV fluids at room temperature
Pre op upper body forced air warming (32˚C)
Use of upper body forced air warming at ambient (32˚C) for at least 30 minutes
Pre op lower body forced air warming (32˚C)
lower body forced air warming at ambient (32˚C) for at least 30 minutes
Pre op fluids (45˚C)
fluids from warmed cabinet set at 45˚C
Intra op upper body forced air warming (32˚C)
Use of upper body forced air warming intra-operative at ambient (32˚C)
Intra op fluids at room temperature
IV fluids at room temperature
Intra op upper body forced air warming at (32˚C)
upper body forced air warming intra-operative at ambient (32˚C)
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Pre op upper body forced air warming (32˚C)
Use of upper body forced air warming at ambient (32˚C) for at least 30 minutes
Pre op lower body forced air warming (32˚C)
lower body forced air warming at ambient (32˚C) for at least 30 minutes
Pre op fluids (45˚C)
fluids from warmed cabinet set at 45˚C
Intra op upper body forced air warming (32˚C)
Use of upper body forced air warming intra-operative at ambient (32˚C)
Intra op fluids at room temperature
IV fluids at room temperature
Intra op upper body forced air warming at (32˚C)
upper body forced air warming intra-operative at ambient (32˚C)
Intra op upper body forced air warming at (42˚C)
upper body forced air warming intra-operative at ambient (42˚C)
Intra op lower body forced air warming at (32˚C)
Lower body forced air warming intra-operative at ambient (32˚C)
Intra op lower body forced air warming at (42˚C)
Lower body forced air warming intra-operative at ambient (42˚C)
Intra op fluid (42˚C)
IV fluids with hotline fluid warmer set at 42˚C
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* singleton pregnancy
Exclusion Criteria
* emergency cesarean
18 Years
FEMALE
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
The University of Texas Health Science Center, Houston
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Stacy Lynn Norrell
Assistant Professor
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Stacy Norrell, MD
Role: PRINCIPAL_INVESTIGATOR
The University of Texas Health Science Center, Houston
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
The University of Texas Health Science Center at Houston
Houston, Texas, United States
Countries
Review the countries where the study has at least one active or historical site.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Facility Contacts
Find local site contact details for specific facilities participating in the trial.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
HSC-MS-21-0011
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.